While the relative toxicity of the accumulating TMEM106B CT aggregates remains uncertain, the presence of TMEM106B amyloid across a variety of neurodegenerative diseases indicates involvement in multi‐proteinopathy driven neurodegeneration. This evidence concerns the gene TMEM106B and neurodegenerative disease.